Autoantibodies against the Ca 2+-binding protein recoverin in blood sera of patients with various oncological diseases

Oncology Letters

Volumn 3, Issue 2, 2012, Pages 377-382

  Savchenko, Marina S ^a   Goncharskaia, Maria A ^b   Skorikova, Elena E ^a   Eichmüller, Stefan B ^c   Kushlinsky, Nikolay E ^b   Bazhin, Alexandr V ^a,c   Philippov, Pavel P ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Autoantibodies against recoverin; Cancer associated retinopathy; Paraneoplastic antigens

Indexed keywords

AUTOANTIBODIES AGAINST RECOVERIN; AUTOANTIBODY; CALCIUM BINDING PROTEIN; RECOVERIN; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ARTICLE; CANCER ASSOCIATED RETINOPATHY; CELL LINE; EYE EXAMINATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG CANCER; RETINOPATHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84855225430     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.464     Document Type: Article

References (22)

1. Adamus G: The role of recoverin in autoimmunity. In: Neuronal Calcium Sensor Proteins. Philippov P and Koch KW (eds). Nova Science Publishers, Inc., New York, NY, pp 181-199, 2006.
2. Dizhur AM, Nekrasova EN and Filippov PP: New 26 kDa protein specific for photoreceptor cells, capable of binding with immobilized delipidized rhodopsin. Biokhimiya 56: 225-229, 1991.
3. Dizhoor AM, Ray S, Kumar S, et al: Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase. Science 251: 915-918, 1991.
4. Philippov PP, Senin II and Koch KW: Recoverin: a calcium-dependent regulator of the visual transduction. In: Neuronal Calcium Sensor Proteins. Philippov P and Koch KW (eds). Nova Science Publishers, Inc., New York, NY, pp 139-151, 2006.
5. Eichmüller SB and Bazhin AV: Onconeural versus paraneoplastic antigens. Cur Med Chem 14: 2489-2494, 2007.
6. Polans AS, Buczylko J, Crabb J and Palczewski K: A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol 112: 981-989, 1991.
7. Polans AS, Witkowska D, Haley TL, et al: Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 92: 9176-9180, 1995.
8. Bazhin AV, Shifrina ON, Savchenko MS, et al: Low titer autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision. Lung Cancer 34: 99-104, 2001.
9. Savchenko MS, Bazhin AV, Shifrina ON, et al: Antirecoverin autoantibodies in the patient with non-small lung cancer but without cancer-associated retinopathy. Lung Cancer 41: 363-367, 2003.
10. Bazhin AV, Savchenko MS, Shifrina ON, et al: Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors. Lung Cancer 44: 193-198, 2004.
11. Bazhin AV, De Smet C, Golovastova MO, et al: Aberrant demethylation of the recoverin gene is involved in the aberrant expression of recoverin in cancer cells. Exp Dermatol 19: 1023-1025, 2011.
12. Bazhin AV, Shifrina ON, Savchenko MS, et al: Application of ELISA and immunoblotting methods for detection of anti-recoverin autoantibodies in sera of small-cell lung carcinoma patients. Pulmonology 13: 62-65, 2003.
13. Senin II, Zargarov AA, Alekseev AM, et al: N-Myristoylation of recoverin enhances its efficiency as an inhibitor of rhodopsin kinase. FEBS Lett 376: 87-90, 1995.
14. Maeda A, Ohguro H, Maeda T, et al: Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Cancer Res 60: 1914-1920, 2000.
15. Bazhin AV, Schadendorf D, Willner N, et al: Photoreceptor proteins as cancer-retina antigens. Int J Cancer 120: 1268-1276, 2007.
16. Graus F, Cordon-Cardo C and Posner JB: Neuronal antinuclear antibody in sensory neuropathy from lung cancer. Neurology 35: 538-543, 1985.
17. Hersh B, Dalmau J, Dangond F, et al: Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurology 44: 1754-1755, 1994.
18. Dalmau J, Furneaux HM, Gralla RJ, et al: Detection of anti-Hu antibody in the serum of patients with small cell lung cancer - a quantitative western blot analysis. Ann Neurol 27: 544-552, 1990.
19. Drlicek M, Bianchi G, Bogliun G, et al: Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J Neurol 244: 85-89, 1997.
20. Bazhin AV, Dalke C, Willner N, et al: Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy. Int J Cancer 124: 140-149, 2009.
21. Matsuo S, Ohguro H, Ohguro I and Nakazawa M: Clinico-pathological roles of aberrantly expressed recoverin in malignant tumor cells. Ophthalmol Res 43: 139-144, 2010.
22. Voltz R, Gultekin SH, Rosenfeld MR, et al: A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Eng J Med 340: 1788-1795, 1999.